[177Lu]DOTA-anti-CD20: Labeling and pre-clinical studies
Saved in:
| Title: | [177Lu]DOTA-anti-CD20: Labeling and pre-clinical studies |
|---|---|
| Authors: | Audicio, Paola F.1 paudicio@cin.edu.uy, Castellano, Gustavo2 gcas@famaf.unc.edu.ar, Tassano, Marcos R.1, Rezzano, Maria E.1, Fernandez, Marcelo1, Riva, Eloisa3, Robles, Ana1, Cabral, Pablo1, Balter, Henia1, Oliver, Patricia1 |
| Source: | Applied Radiation & Isotopes. Jul2011, Vol. 69 Issue 7, p924-928. 5p. |
| Subjects: | Rituximab, Radioimmunotherapy, Lymphomas, Monoclonal antibodies, Radiopharmaceuticals, Radioactive tracers, Monte Carlo method, Radiochemistry |
| Abstract: | Abstract: Anti-CD20 (Rituximab®), a specific chimeric monoclonal antibody used in CD20-positive Non-Hodgkin''s Lymphoma, was conjugated to a bifunctional quelate (DOTA) and radiolabeled with 177Lu through a simple method. [177Lu]-DOTA-anti-CD20 was obtained with a radiochemical purity higher than 97%, and showed good chemical and biological stability, maintaining its biospecificity to CD20 antigens. Monte Carlo simulation showed high doses deposited on a spheroid tumor mass model. This method seems to be an appropriate alternative for the production of [177Lu]-DOTA-anti-CD20 as therapeutic radiopharmaceutical. [Copyright &y& Elsevier] |
| Copyright of Applied Radiation & Isotopes is the property of Pergamon Press - An Imprint of Elsevier Science and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: egs DbLabel: Engineering Source An: 60565424 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: [<superscript>177</superscript>Lu]DOTA-anti-CD20: Labeling and pre-clinical studies – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Audicio%2C+Paola+F%2E%22">Audicio, Paola F.</searchLink><relatesTo>1</relatesTo><i> paudicio@cin.edu.uy</i><br /><searchLink fieldCode="AR" term="%22Castellano%2C+Gustavo%22">Castellano, Gustavo</searchLink><relatesTo>2</relatesTo><i> gcas@famaf.unc.edu.ar</i><br /><searchLink fieldCode="AR" term="%22Tassano%2C+Marcos+R%2E%22">Tassano, Marcos R.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Rezzano%2C+Maria+E%2E%22">Rezzano, Maria E.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Fernandez%2C+Marcelo%22">Fernandez, Marcelo</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Riva%2C+Eloisa%22">Riva, Eloisa</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Robles%2C+Ana%22">Robles, Ana</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Cabral%2C+Pablo%22">Cabral, Pablo</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Balter%2C+Henia%22">Balter, Henia</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Oliver%2C+Patricia%22">Oliver, Patricia</searchLink><relatesTo>1</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Applied+Radiation+%26+Isotopes%22">Applied Radiation & Isotopes</searchLink>. Jul2011, Vol. 69 Issue 7, p924-928. 5p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Rituximab%22">Rituximab</searchLink><br /><searchLink fieldCode="DE" term="%22Radioimmunotherapy%22">Radioimmunotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Lymphomas%22">Lymphomas</searchLink><br /><searchLink fieldCode="DE" term="%22Monoclonal+antibodies%22">Monoclonal antibodies</searchLink><br /><searchLink fieldCode="DE" term="%22Radiopharmaceuticals%22">Radiopharmaceuticals</searchLink><br /><searchLink fieldCode="DE" term="%22Radioactive+tracers%22">Radioactive tracers</searchLink><br /><searchLink fieldCode="DE" term="%22Monte+Carlo+method%22">Monte Carlo method</searchLink><br /><searchLink fieldCode="DE" term="%22Radiochemistry%22">Radiochemistry</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Abstract: Anti-CD20 (Rituximab®), a specific chimeric monoclonal antibody used in CD20-positive Non-Hodgkin''s Lymphoma, was conjugated to a bifunctional quelate (DOTA) and radiolabeled with 177Lu through a simple method. [177Lu]-DOTA-anti-CD20 was obtained with a radiochemical purity higher than 97%, and showed good chemical and biological stability, maintaining its biospecificity to CD20 antigens. Monte Carlo simulation showed high doses deposited on a spheroid tumor mass model. This method seems to be an appropriate alternative for the production of [177Lu]-DOTA-anti-CD20 as therapeutic radiopharmaceutical. [Copyright &y& Elsevier] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Applied Radiation & Isotopes is the property of Pergamon Press - An Imprint of Elsevier Science and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=60565424 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.apradiso.2011.01.026 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 5 StartPage: 924 Subjects: – SubjectFull: Rituximab Type: general – SubjectFull: Radioimmunotherapy Type: general – SubjectFull: Lymphomas Type: general – SubjectFull: Monoclonal antibodies Type: general – SubjectFull: Radiopharmaceuticals Type: general – SubjectFull: Radioactive tracers Type: general – SubjectFull: Monte Carlo method Type: general – SubjectFull: Radiochemistry Type: general Titles: – TitleFull: [177Lu]DOTA-anti-CD20: Labeling and pre-clinical studies Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Audicio, Paola F. – PersonEntity: Name: NameFull: Castellano, Gustavo – PersonEntity: Name: NameFull: Tassano, Marcos R. – PersonEntity: Name: NameFull: Rezzano, Maria E. – PersonEntity: Name: NameFull: Fernandez, Marcelo – PersonEntity: Name: NameFull: Riva, Eloisa – PersonEntity: Name: NameFull: Robles, Ana – PersonEntity: Name: NameFull: Cabral, Pablo – PersonEntity: Name: NameFull: Balter, Henia – PersonEntity: Name: NameFull: Oliver, Patricia IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: Jul2011 Type: published Y: 2011 Identifiers: – Type: issn-print Value: 09698043 Numbering: – Type: volume Value: 69 – Type: issue Value: 7 Titles: – TitleFull: Applied Radiation & Isotopes Type: main |
| ResultId | 1 |